Literature DB >> 22425350

Atomic resolution model of the antibody Fc interaction with the complement C1q component.

Sebastian Schneider1, Martin Zacharias.   

Abstract

The globular C1q heterotrimer is a subunit of the C1 complement factor. Binding of the C1q subunit to the constant (Fc) part of antibody molecules is a first step and key event of complement activation. Although three-dimensional structures of C1q and antibody Fc subunits have been determined experimentally no atomic resolution structure of the C1q-Fc complex is known so far. Based on systematic protein-protein docking searches and Molecular Dynamics simulations a structural model of the C1q-IgG1-Fc-binding geometry has been obtained. The structural model is compatible with available experimental data on the interaction between the two partner proteins. It predicts a binding geometry that involves mainly the B-subunit of the C1q-trimer and both subunits of the IgG1-Fc-dimer with small conformational adjustments with respect to the unbound partners to achieve high surface complementarity. In addition to several charge-charge and polar contacts in the rim region of the interface it also involves nonpolar contacts between the two proteins and is compatible with the carbohydrate moiety of the Fc subunit. The model for the complex structure provides a working model for rationalizing available biochemical data on this important interaction and can form the basis for the design of Fc variants with a greater capacity to activate the complement system for example on binding to cancer cells or other target structures.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22425350     DOI: 10.1016/j.molimm.2012.02.111

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  18 in total

1.  Fc Engineering of Human IgG1 for Altered Binding to the Neonatal Fc Receptor Affects Fc Effector Functions.

Authors:  Algirdas Grevys; Malin Bern; Stian Foss; Diane Bryant Bratlie; Anders Moen; Kristin Støen Gunnarsen; Audun Aase; Terje Einar Michaelsen; Inger Sandlie; Jan Terje Andersen
Journal:  J Immunol       Date:  2015-04-22       Impact factor: 5.422

2.  The solution structures of two human IgG1 antibodies show conformational stability and accommodate their C1q and FcγR ligands.

Authors:  Lucy E Rayner; Gar Kay Hui; Jayesh Gor; Richard K Heenan; Paul A Dalby; Stephen J Perkins
Journal:  J Biol Chem       Date:  2015-02-06       Impact factor: 5.157

3.  TUNABLE COMPLEMENT ACTIVATION BY PARTICLES WITH VARIABLE SIZE AND Fc DENSITY.

Authors:  Patricia M Pacheco; Benjamin LE; David White; Todd Sulchek
Journal:  Nano Life       Date:  2013-06

4.  IgG Fc domains that bind C1q but not effector Fcγ receptors delineate the importance of complement-mediated effector functions.

Authors:  Chang-Han Lee; Gabrielle Romain; Wupeng Yan; Makiko Watanabe; Wissam Charab; Biliana Todorova; Jiwon Lee; Kendra Triplett; Moses Donkor; Oana I Lungu; Anja Lux; Nicholas Marshall; Margaret A Lindorfer; Odile Richard-Le Goff; Bianca Balbino; Tae Hyun Kang; Hidetaka Tanno; George Delidakis; Corrine Alford; Ronald P Taylor; Falk Nimmerjahn; Navin Varadarajan; Pierre Bruhns; Yan Jessie Zhang; George Georgiou
Journal:  Nat Immunol       Date:  2017-06-12       Impact factor: 25.606

5.  Site-specific antibody-drug conjugation through an engineered glycotransferase and a chemically reactive sugar.

Authors:  Zhongyu Zhu; Boopathy Ramakrishnan; Jinyu Li; Yanping Wang; Yang Feng; Ponraj Prabakaran; Simona Colantonio; Marzena A Dyba; Pradman K Qasba; Dimiter S Dimitrov
Journal:  MAbs       Date:  2014-10-30       Impact factor: 5.857

6.  Structure of full-length human anti-PD1 therapeutic IgG4 antibody pembrolizumab.

Authors:  Giovanna Scapin; Xiaoyu Yang; Winifred W Prosise; Mark McCoy; Paul Reichert; Jennifer M Johnston; Ramesh S Kashi; Corey Strickland
Journal:  Nat Struct Mol Biol       Date:  2015-11-23       Impact factor: 15.369

7.  An Fc Double-Engineered CD20 Antibody with Enhanced Ability to Trigger Complement-Dependent Cytotoxicity and Antibody-Dependent Cell-Mediated Cytotoxicity.

Authors:  Tim Wirt; Sophia Rosskopf; Thies Rösner; Klara Marie Eichholz; Anne Kahrs; Sebastian Lutz; Anna Kretschmer; Thomas Valerius; Katja Klausz; Anna Otte; Martin Gramatzki; Matthias Peipp; Christian Kellner
Journal:  Transfus Med Hemother       Date:  2017-09-11       Impact factor: 3.747

8.  Leporid immunoglobulin G shows evidence of strong selective pressure on the hinge and CH3 domains.

Authors:  Ana Pinheiro; Jenny M Woof; Tereza Almeida; Joana Abrantes; Paulo C Alves; Christian Gortázar; Pedro J Esteves
Journal:  Open Biol       Date:  2014-09       Impact factor: 6.411

9.  Structural determinants of unique properties of human IgG4-Fc.

Authors:  Anna M Davies; Theo Rispens; Pleuni Ooijevaar-de Heer; Hannah J Gould; Roy Jefferis; Rob C Aalberse; Brian J Sutton
Journal:  J Mol Biol       Date:  2013-11-06       Impact factor: 5.469

10.  The Fab conformations in the solution structure of human immunoglobulin G4 (IgG4) restrict access to its Fc region: implications for functional activity.

Authors:  Lucy E Rayner; Gar Kay Hui; Jayesh Gor; Richard K Heenan; Paul A Dalby; Stephen J Perkins
Journal:  J Biol Chem       Date:  2014-05-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.